nodes	percent_of_prediction	percent_of_DWPC	metapath
Betazole—HRH2—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.188	0.188	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0511	0.0511	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0501	0.0501	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.043	0.043	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0421	0.0421	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0303	0.0303	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0292	0.0292	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0282	0.0282	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0273	0.0273	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0269	0.0269	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0265	0.0265	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0255	0.0255	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0247	0.0247	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0237	0.0237	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.023	0.023	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0226	0.0226	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0223	0.0223	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0208	0.0208	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0174	0.0174	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0173	0.0173	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0145	0.0145	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00987	0.00987	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00978	0.00978	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00967	0.00967	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0096	0.0096	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00845	0.00845	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00828	0.00828	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0067	0.0067	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00644	0.00644	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00631	0.00631	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00586	0.00586	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00574	0.00574	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00544	0.00544	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00542	0.00542	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00527	0.00527	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00518	0.00518	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00512	0.00512	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00502	0.00502	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00493	0.00493	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00477	0.00477	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00467	0.00467	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00452	0.00452	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00444	0.00444	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00439	0.00439	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00437	0.00437	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00409	0.00409	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00382	0.00382	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00364	0.00364	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00356	0.00356	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00355	0.00355	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00344	0.00344	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00338	0.00338	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00334	0.00334	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00334	0.00334	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0033	0.0033	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00324	0.00324	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00311	0.00311	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00291	0.00291	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00286	0.00286	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00247	0.00247	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00227	0.00227	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00224	0.00224	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00218	0.00218	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00216	0.00216	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00201	0.00201	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00196	0.00196	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00195	0.00195	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00194	0.00194	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00191	0.00191	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00191	0.00191	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00189	0.00189	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00188	0.00188	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00182	0.00182	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00177	0.00177	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00176	0.00176	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00174	0.00174	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00171	0.00171	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0016	0.0016	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00133	0.00133	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00123	0.00123	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00116	0.00116	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00112	0.00112	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00108	0.00108	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00104	0.00104	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00103	0.00103	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00101	0.00101	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000943	0.000943	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000661	0.000661	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00035	0.00035	CbGpPWpGaD
